Compare LQDA & AUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LQDA | AUB |
|---|---|---|
| Founded | 2004 | 1902 |
| Country | United States | United States |
| Employees | N/A | 3064 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.1B |
| IPO Year | 2020 | N/A |
| Metric | LQDA | AUB |
|---|---|---|
| Price | $78.03 | $41.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | $41.00 | ★ $41.88 |
| AVG Volume (30 Days) | ★ 2.4M | 1.0M |
| Earning Date | 05-08-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.98% |
| EPS Growth | ★ 51.81 | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $158,320,000.00 | N/A |
| Revenue This Year | $278.87 | $29.16 |
| Revenue Next Year | $57.13 | $4.59 |
| P/E Ratio | $147.92 | ★ $19.68 |
| Revenue Growth | ★ 1031.18 | N/A |
| 52 Week Low | $11.85 | $30.39 |
| 52 Week High | $78.25 | $42.18 |
| Indicator | LQDA | AUB |
|---|---|---|
| Relative Strength Index (RSI) | 75.44 | 68.73 |
| Support Level | $31.23 | $36.35 |
| Resistance Level | N/A | $42.18 |
| Average True Range (ATR) | 4.14 | 0.86 |
| MACD | 0.40 | 0.27 |
| Stochastic Oscillator | 91.55 | 95.29 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.